A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Pfizer
City of Hope Medical Center
Novartis
Case Comprehensive Cancer Center
Corvus Pharmaceuticals, Inc.
Centre Leon Berard
Targovax ASA